Pulnovo Medical Obtains IDE Approvals for PADN Clinical Trials with CMS Coverage Pulnovo Medical has secured two IDE approvals for the PADN system's clinical trials, paving the way for significant advancements in treating pulmonary hypertension and heart failure.

Pulnovo Medical Obtains IDE Approvals for PADN Clinical Trials with CMS Coverage #Shanghai #USA #Clinical_Trials #Pulnovo_Medical #PADN

Pulnovo Medical Secures Nearly $100 Million in Series C Financing to Advance Heart Health Innovations Pulnovo Medical successfully concludes its nearly $100 million Series C financing round, aiming for global expansion and innovative heart treatment advances in pulmonary hypertension.

Pulnovo Medical Secures Nearly $100 Million in Series C Financing to Advance Heart Health Innovations #China #Shanghai #Pulnovo_Medical #PADN #Qiming_Venture